Stock market today: Nasdaq edges back from its record as chip companies and Eli Lilly slump
U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent ...
Indexes slip lower with drops for Lilly, chip giants
U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google's parent ...
Las Vegas Sun32m
Stock market today: Asia shares mostly decline as investors await earnings, US elections
Upcoming earnings releases in Asia, as well as the rest of the world, also added to the wait-and-see mood. On Wall Street, the S&P 500 slipped 0.3% to 5,813.67 after drifting between small gains and ...
Marshall Independent1h
Nasdaq edges back from its record as chip companies and Eli Lilly slump
U.S. stock indexes edged lower Wednesday after drops for Eli Lilly and chip companies overshadowed a jump for Google’s parent company. The S&P 500 slipped 0.3% after drifting between small gains and ...
Access WDUN4h
Stock market today: Wall Street wavers as Alphabet jumps on Google profits and Eli Lilly slumps
U.S. stock indexes are wavering following a strong profit report from Google’s parent company, while drops for Eli Lilly and ...
Daniels, former governor and Purdue president, will speak at Indiana State U. in February
Mitch Daniels, former governor of Indiana and president emeritus of Purdue University, will speak at 7 p.m. Feb. 17 at Tilson Auditorium, Indiana State University. The event is part of the school’s ...
thedailyupside7h
Pharmapalooza: Earnings Highlight Highs and Lows of Cutthroat Sector
It’s just another earnings week in the life of pharmaceutical CEOs, with blockbuster expectations running up against cruel ...
Eli Lilly's miss explanation is 'totally opaque', says Jim Cramer
Fly over the electrifying scenes of India’s Holi Festival with this mesmerizing drone footage. Watch as crowds gather to ...
Stocks hit pause after Nasdaq milestone; Eli Lilly earnings underwhelm Wall St.
The S&P 500 slipped 0.3 percent after drifting between small gains and losses several times, though it's still near its ...
Eli Lilly plans to begin advertising weight-loss drug Zepbound
Eli Lilly ( LLY) is planning to advertise its blockbuster weight loss drug, Zepbound, for the first time next month. Despite investor and industry recognition of the branded GLP-1 drug, "unaided ...